Header
 
Login
 

Privatsphäre-Einstellungen

Wir verwenden Cookies auf unserer Website. Einige von ihnen sind unerlässlich, während andere uns helfen, diese Website und Ihre Erfahrungen zu verbessern.

Notwendig Statistik Marketing
Auswahl bestätigen
Weitere Einstellungen

Hier finden Sie eine Übersicht aller verwendeten Cookies. Sie können ganzen Kategorien Ihre Zustimmung geben oder weitere Informationen anzeigen und bestimmte Cookies auswählen.

Alle auswählen
Auswahl bestätigen
Notwendig Cookies
Wesentliche Cookies ermöglichen grundlegende Funktionen und sind für die ordnungsgemäße Funktion der Website erforderlich.
Statistik Cookies
Statistik-Cookies sammeln anonym Informationen. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing Cookies
Marketing-Cookies werden von Werbekunden oder Publishern von Drittanbietern verwendet, um personalisierte Anzeigen zu schalten. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen
Zurück
    Clinical Data Interchange Standards Consortium - Goals, Mission, Accomplishments

    Rebecca Daniels Kusha and Udo Siegmannb

    Clinical Data Interchange Standards Consortiuma, Austin (Texas, USA), and PAREXELb, Berlin (Germany)

    The Clinical Data Interchange Standards Consortium (CDISC) is developing industry-wide standards to facilitate the acquisition, exchange, submission and archive of electronic clinical data for the biopharmaceutical product development industry. Long-term desired outcomes of CDISC are:

    • A holistic approach to standards, facilitating data interchange from sites through regulatory submission, utilizing XML;

    • Standards for data acquisition supporting the population of cross-trial warehouses and standard review tools;

    • HL7- (Health Level 7) CDISC models harmonized to yield value for both clinical research and healthcare, thus supporting the electronic sharing of information between health records and clinical trials;

    • Global adoption of CDISC data standards.

    Four CDISC standards are now available: Operational Data Model (ODM) Version 1.2; Laboratory Data Standards (LAB) Version 1.0.1; Submission Data Standard (SDS) Version 3; and a set of Analysis Dataset Models. The first two are focused on data acquisition and the last two on data submission and review. The primary activities of the CDISC volunteer modeling teams, at this point, are directed towards stabilizing and ensuring interoperability among these CDISC standards, themselves, and with the healthcare data standard (Reference Information Model) developed through HL7.
    CDISC has a formal relationship with HL7 and collaborates directly with HL7 and FDA and other interested groups through the Regulated Clinical Research Information Management (RCRIM) Technical Committee. There are additional standards being developed and accredited through the RCRIM, including Submission Data Standards for

    • animal data,
    • product stability data,
    • clinical trial protocol representation standards,
    • ECG waveform standards.

    A key opportunity recognized for CDISC and HL7 is to be able to develop common informatics platforms for the improved sharing of clinical research data and healthcare data. Such standards would improve processes for all involved with clinical research - clinicians and investigators, biopharmaceutical industry stakeholders and regulatory reviewers.

    Key words Clinical Data Interchange Standards Consortium • Clinical data management




    © ECV- Editio Cantor Verlag (Germany) 2004

     

    pharmind 2004, Nr. 05a, Seite 654